NC Testing in LC & POTS
Neurocognitive Testing in Long COVID and Postural Tachycardia Syndrome Patients With Normal Saline: A Pilot Study
University of Calgary
100 participants
Sep 19, 2024
INTERVENTIONAL
Conditions
Summary
Patients with Postural Orthostatic Tachycardia Syndrome (POTS) and Post-Acute Sequelae of COVID (PASC, or "Long COVID") experience cognitive dysfunction. The investigators will test the hypothesis that 999 mL of IV saline will improve cognitive function in patients with POTS and Long COVID compared to placebo (50 mL of saline).
Eligibility
Inclusion Criteria11
- Patients with diagnosis of Long COVID
- SARS-COV2 test positive
- Symptoms > 12 weeks post COVID
- Subjective complaint of 'brain fog" or cognitive dysfunction
- Patients with diagnosis of Postural Orthostatic Syndrome (POTS) from the Calgary Autonomic Investigation and Management Clinic
- Subjective complaint of 'brain fog" or cognitive impairment
- Healthy participants
- Without POTS or "brain fog"
- Age 18 to 60 years
- Female and Male
- Able to give an informed consent
Exclusion Criteria4
- Patients with overt causes for POTS (e.g., dehydration, prolonged bed rest)
- An inability to safely withdraw from medicine(s) that could make test interpretation difficult and impossible.
- Other factors which are in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies or an unpredictable schedule.
- Unable to give an informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
999 mL of IV normal saline will be infused intravenously
50 mL of IV normal saline will be infused intravenously as a placebo control.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05914649